Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1991 1
1992 3
1993 1
1994 3
1998 2
2000 6
2001 2
2002 10
2003 3
2004 7
2005 1
2006 8
2007 2
2008 4
2010 5
2011 5
2012 7
2013 15
2014 12
2015 11
2016 11
2017 11
2018 13
2019 10
2020 14
2021 18
2022 18
2023 14
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Results by year

Filters applied: . Clear all
Page 1
Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Miethke AG, Moukarzel A, Porta G, Covarrubias Esquer J, Czubkowski P, Ordonez F, Mosca A, Aqul AA, Squires RH, Sokal E, D'Agostino D, Baumann U, D'Antiga L, Kasi N, Laborde N, Arikan C, Lin CH, Gilmour S, Mittal N, Chiou FK, Horslen SP, Huber WD, Jaecklin T, Nunes T, Lascau A, Longpre L, Mogul DB, Garner W, Vig P, Hupertz VF, Gonzalez-Peralta RP, Ekong U, Hartley J, Laverdure N, Ovchinsky N, Thompson RJ. Miethke AG, et al. Among authors: horslen sp. Lancet Gastroenterol Hepatol. 2024 May 6:S2468-1253(24)00080-3. doi: 10.1016/S2468-1253(24)00080-3. Online ahead of print. Lancet Gastroenterol Hepatol. 2024. PMID: 38723644
Sepsis during short bowel syndrome hospitalizations: Identifying trends, disparities, and clinical outcomes in the United States.
Dahiya DS, Wachala J, Solanki S, Solanki D, Kichloo A, Holcomb S, Mansuri U, Haq KS, Ali H, Gangwani MK, Shah YR, Varghese T, Khan HMA, Horslen SP, Schiano TD, Jafri SM. Dahiya DS, et al. Among authors: horslen sp. World J Gastrointest Pathophysiol. 2024 Apr 22;15(1):92085. doi: 10.4291/wjgp.v15.i1.92085. World J Gastrointest Pathophysiol. 2024. PMID: 38682025 Free PMC article.
Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium.
Ricciuto A, Liu K, El-Matary W, Amin M, Amir AZ, Aumar M, Auth M, Di Guglielmo MD, Druve Tavares Fagundes E, Rodrigues Ferreira A, Furuya KN, Gupta N, Guthery S, Horslen SP, Jensen K, Kamath BM, Kerkar N, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Mack C, Martinez M, Montano-Loza A, Ovchinsky N, Papadopoulou A, Perito ER, Sathya P, Schwarz KB, Shah U, Shteyer E, Soufi N, Stevens JP, Taylor A, Tessier ME, Valentino P, Woynarowski M, Deneau M; Pediatric PSC Consortium. Ricciuto A, et al. Among authors: horslen sp. Aliment Pharmacol Ther. 2024 May;59(10):1236-1247. doi: 10.1111/apt.17936. Epub 2024 Mar 10. Aliment Pharmacol Ther. 2024. PMID: 38462727
Diagnostic accuracy of serum matrix metalloproteinase-7 as a biomarker of biliary atresia in a large North American cohort.
Pandurangi S, Mourya R, Nalluri S, Fei L, Dong S, Harpavat S, Guthery SL, Molleston JP, Rosenthal P, Sokol RJ, Wang KS, Ng V, Alonso EM, Hsu EK, Karpen SJ, Loomes KM, Magee JC, Shneider BL, Horslen SP, Teckman JH, Bezerra JA; Childhood Liver Disease Research Network. Pandurangi S, et al. Among authors: horslen sp. Hepatology. 2024 Mar 6. doi: 10.1097/HEP.0000000000000827. Online ahead of print. Hepatology. 2024. PMID: 38446707
OPTN/SRTR 2022 Annual Data Report: Intestine.
Horslen SP, Ahn YS, Wood NL, Schnellinger EM, Gauntt K, McDermott M. Horslen SP, et al. Am J Transplant. 2024 Feb;24(2S1):S266-S304. doi: 10.1016/j.ajt.2024.01.015. Am J Transplant. 2024. PMID: 38431361
Enhanced Donor Antigen Presentation by B Cells Predicts Acute Cellular Rejection and Late Outcomes After Transplantation.
Ashokkumar C, Ningappa M, Raghu V, Mazariegos G, Higgs BW, Morgan P, Remaley L, Fazzolare Martin T, Holzer P, Trostle K, Xu Q, Zeevi A, Squires J, Soltys K, Horslen S, Khanna A, Ganoza A, Sindhi R. Ashokkumar C, et al. Among authors: horslen s. Transplant Direct. 2024 Feb 26;10(3):e1589. doi: 10.1097/TXD.0000000000001589. eCollection 2024 Mar. Transplant Direct. 2024. PMID: 38414976 Free PMC article.
Equipoise in pediatric acute liver failure.
Chapin CA, Squires JE, Horslen SP, Alonso EM. Chapin CA, et al. Among authors: horslen sp. J Pediatr Gastroenterol Nutr. 2024 May;78(5):1001-1004. doi: 10.1002/jpn3.12166. Epub 2024 Feb 26. J Pediatr Gastroenterol Nutr. 2024. PMID: 38409886 No abstract available.
Impact of early immunosuppression on pediatric liver transplant outcomes within 1 year.
Raghu VK, Zhang X, Squires JE, Eisenberg E, Feldman AG, Halma J, Peters AL, Gonzalez-Peralta RP, Ng VL, Horslen SP, Lobritto SJ, Bucuvalas J, Mazariegos GV, Perito ER. Raghu VK, et al. Among authors: horslen sp. J Pediatr Gastroenterol Nutr. 2024 Feb;78(2):328-338. doi: 10.1002/jpn3.12112. Epub 2024 Jan 2. J Pediatr Gastroenterol Nutr. 2024. PMID: 38374561
Protein biomarkers GDF15 and FGF21 to differentiate mitochondrial hepatopathies from other pediatric liver diseases.
Van Hove JLK, Friederich MW, Strode DK, Van Hove RA, Miller KR, Sharma R, Shah H, Estrella J, Gabel L, Horslen S, Kohli R, Lovell MA, Miethke AG, Molleston JP, Romero R, Squires JE, Alonso EM, Guthery SL, Kamath BM, Loomes KM, Rosenthal P, Mysore KR, Cavallo LA, Valentino PL, Magee JC, Sundaram SS, Sokol RJ; Childhood Liver Disease Research Network (ChiLDReN). Van Hove JLK, et al. Among authors: horslen s. Hepatol Commun. 2024 Jan 5;8(1):e0361. doi: 10.1097/HC9.0000000000000361. eCollection 2024 Jan 1. Hepatol Commun. 2024. PMID: 38180987 Free PMC article.
205 results